3,079 results
Search Results
52. Interindividual differences in chlorthalidone concentration in plasma and red cells of man after single and multiple doses
53. Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency
54. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection
55. Effect of enterohepatic circulation on the pharmacokinetics of spironolactone in man
56. Evaluation of a micromethod for determination of antibiotic concentrations in plasma
57. Biochemistry and pharmacology of the crotoxin complex: II. Possible interrelationships between toxicity and organ distribution of phospholipase A, crotapotin and their combination
58. Prenatal exposure to escitalopram and/or stress in rats: A prenatal stress model of maternal depression and its treatment
59. Effect of ABCB1 polymorphisms and atorvastatin on sitagliptin pharmacokinetics in healthy volunteers
60. Assessment of the absorption, metabolism and excretion of [14C]pasireotide in healthy volunteers using accelerator mass spectrometry
61. Dopamine D2/3 occupancy of ziprasidone across a day: a within-subject PET study
62. The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases
63. Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
64. Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection
65. Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors
66. Simultaneous Determination of α- and γ-Mangostins in Mouse Plasma by HPLC–MS/MS Method: Application to a Pharmacokinetic Study of Mangosteen Extract in Mouse
67. Hollow-Fiber-Based LPME as a Reliable Sampling Method for Gas-Chromatographic Determination of Pharmacokinetic Parameters of Valproic Acid in Rat Plasma
68. Bioavailability of intravenous fosphenytoin sodium in healthy Japanese volunteers
69. Pharmacokinetics and metabolism of SL-01, a prodrug of gemcitabine, in rats
70. Influence of Bariatric Surgery on the Use and Pharmacokinetics of Some Major Drug Classes
71. Correlation of contrast agent kinetics between iodinated contrast-enhanced spectral tomosynthesis and gadolinium-enhanced MRI of breast lesions
72. Pharmacokinetics, Tissue Distribution and Excretion of Recombinant Human Parathyroid Hormone 1–84 in Animals
73. Pharmacokinetic disposition of anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in rats and dogs
74. C max and t max verification using Fibonacci sequence and absorption rate
75. Phase I study of oral gemcitabine prodrug (LY2334737) in Japanese patients with advanced solid tumors
76. Pharmacokinetics and tissue distribution of larotaxel in rats: comparison of larotaxel-loaded microsphere with larotaxel-solution
77. Validated LC-ESI-MS/MS Method for the Quantitation of Neopanaxadiol: a Novel Neuroprotective Agent from Panax ginseng and Its Application to a Pharmacokinetic Study in Rat Plasma
78. Pharmakokinetische Parameter: Altersbedingte Änderungen und Einfluss auf die Therapiefähigkeit
79. A phase I pharmacokinetic study of PM00104 (Zalypsis®) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors
80. Simultaneous Quantification of Aliskiren, Valsartan and Sitagliptin by LC with Fluorescence Detection: Evidence of Pharmacokinetic Interaction in Rats
81. Pharmacokinetics of teduglutide in subjects with renal impairment
82. Therapeutic drug monitoring for tomorrow
83. Pharmacokinetics Study of Amoxycillin and Clavulanic acid (8:1)-A New Combination in Healthy Chinese Adult Male Volunteers Using the LC–MS/MS Method
84. Correlations between the selected parameters of the chemical structure of drugs and between-subject variability in area under the curve
85. A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens
86. Effect of the P450 oxidoreductase *28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers
87. Evaluation of chemically diverse 5-HT2C receptor agonists on behaviours motivated by food and nicotine and on side effect profiles
88. Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects
89. CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects
90. Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers
91. A phase I study of tasisulam sodium using an albumin-tailored dose in Japanese patients with advanced solid tumors
92. A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray
93. Medikamentöse Therapie bei Frauen – Was gilt es zu beachten?
94. Strategien zur Vermeidung von Antibiotikaresistenzen
95. Pharmacokinetic and tolerability profile of pridopidine in healthy-volunteer poor and extensive CYP2D6 metabolizers, following single and multiple dosing
96. Single ascending oral dose pharmacokinetics and pharmacodynamics study of EV-077: the specific inhibitor of prostanoid- and isoprostane-induced cellular activation
97. Effects of pyridoxine on the intestinal absorption and pharmacokinetics of isoniazid in rats
98. Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers
99. Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis
100. Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR)
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.